FMP
Nov 18, 2025
On November 18, 2025, Actelis Networks, Inc. (NASDAQ:ASNS) executed a reverse stock split at a ratio of 10 for 1. This corporate action is often used by companies to increase the per-share price by reducing the number of shares outstanding. ASNS is part of the Zacks Communication - Components industry, focusing on expanding its cybersecurity, hardware, and software sales across telecom and infrastructure networks.
ASNS reported a quarterly loss of $0.17 per share, missing the Zacks Consensus Estimate of a $0.13 loss. This represents a 30.77% negative surprise, highlighting the company's ongoing financial challenges. The loss also marks a decline from the previous year's loss of $0.09 per share. Over the past four quarters, ASNS has only surpassed consensus EPS estimates once, indicating a pattern of underperformance.
The company's revenue for the quarter ending September 2025 was $640,000, significantly below the Zacks Consensus Estimate by 57.13%. This is a sharp decline from the $2.54 million reported a year ago. ASNS has consistently failed to meet consensus revenue estimates over the last four quarters, reflecting ongoing difficulties in achieving expected financial targets.
Despite these challenges, ASNS is making strategic advancements. The company nearly doubled its customer bookings compared to the second quarter and is entering the fourth quarter with a stronger backlog of orders. This growth is supported by the recent hiring of U.S. Federal Sales leadership, which is expected to enhance market opportunities, particularly in Federal and Multi-Dwelling Unit (MDU) markets.
ASNS is also implementing a reorganization and efficiency plan, aiming to reduce operating expenses by 15-20% annually. Despite a softer quarter in Federal revenue, CEO Tuvia Barlev remains optimistic about the company's future prospects. The stock is currently priced at $0.32, reflecting a decrease of 18.02% with a market capitalization of approximately $2.9 million.
Medtronic (NYSE:MDT) is a leading global healthcare technology company that develops and manufactures medical devices an...
BellRing Brands, Inc. (NYSE: BRBR) operates in the global convenient nutrition sector, providing products that cater to ...